Innovative strategies in gastrointestinal cancer Gerald Prager editorial 16 February 2022 Pages: 1 - 2
New frontiers in chronic lymphocytic leukemia on the way to curing the disease Philipp Staber editorial 16 February 2022 Pages: 3 - 3
Toxicity management in severe and refractory cases—what we have learned Matthias Preusser editorial 16 February 2022 Pages: 4 - 4
Hepatocellular carcinoma—neoadjuvant systemic and local treatment concepts to improve resectability rates and oncological outcome Iveta UrbanFlorian PrimavesiStefan Stättner short review 03 February 2022 Pages: 5 - 11
Thyroid metastasectomy for deposits from colorectal cancer: case report and non-systematic review Waleed ElnahasIslam H. MetwallyWagdi Elkashef case report 10 June 2021 Pages: 12 - 19
Immunotherapy—another breakthrough in gastrointestinal malignancies Monika LenziThomas Winder short review 27 January 2022 Pages: 20 - 25
Neoadjuvant versus adjuvant management of resectable pancreas cancer: A review of the literature Konstantin Schlick review Open access 08 September 2021 Pages: 26 - 28
Innovative strategies in metastatic gastric cancer: a short review Hannah Christina PuhrAysegul Ilhan-Mutlu short review Open access 19 October 2021 Pages: 29 - 34
Practice-changing strategies in the treatment of esophageal cancer Ercan MüldürWolfgang Hilbe short review 22 December 2021 Pages: 35 - 38
Treatment decision based on molecular profiling in metastatic colorectal cancer with a focus on RAS pathway mutations Johannes SchöcheDora Niedersüß-Beke short review 14 January 2022 Pages: 39 - 44
Bcl2 inhibitor venetoclax +/− Anti-CD20: what do deep remissions mean? Katharina T. ProchazkaBarbara Uhl short review Open access 22 December 2021 Pages: 45 - 48
BTKi, venetoclax, obinutuzumab: what is the ideal combination? Daniel Heintel short review 20 December 2021 Pages: 49 - 52
New actionable targets and investigational drugs in chronic lymphocytic leukemia Jan-Paul Bohn short review Open access 05 October 2021 Pages: 53 - 57
Immune-related hepatitis in a patient with hepatocellular carcinoma treated with nivolumab Bernhard ScheinerMatthias Pinter case report Open access 09 September 2021 Pages: 58 - 61
Checkpoint inhibitor pneumonitis: Short review of literature and case report Romana Elisabeth WassDavid LangBernd Lamprecht short review Open access 06 October 2021 Pages: 62 - 66
Cardiotoxicity—current recommendations of prevention and treatment Jutta Bergler-Klein short review Open access 04 November 2021 Pages: 67 - 71
Clinical challenges in the management of endocrine side effects of immuno-oncological therapies Peter WolfThomas Scherer short review Open access 24 November 2021 Pages: 72 - 75
Palliative care: patient’s autonomy in the end-of-life situation Bert Engelhardt case report 04 January 2022 Pages: 76 - 78
Chronic myeloid leukemia associated with acquired von Willebrand syndrome: A case report Prachi MohapatraSatya Prasad Mahapatra case report 26 October 2021 Pages: 79 - 82
The outcome of COVID-19 in patients with hematological malignancy Pınar TığlıoğluMurat AlbayrakSenem Maral original report 09 December 2021 Pages: 83 - 89
Clinical characteristics and prognostic value of 1q21 gain detected by fluorescence in situ hybridization in patients with newly diagnosed multiple myeloma Xiao XiaoXinchen FangZhu Huaiping original report 22 November 2021 Pages: 90 - 93